Skip to main content
Premium Trial:

Request an Annual Quote

Missouri-Based Firm Buys Receptor Research

Premium

ST. LOUIS, Mo.--Tripos, a molecular informatics, design, and analysis company here, has acquired Receptor Research, a specialty chemistry company based in Bude, Cornwall. The purchase allows Tripos to directly apply its expertise in new compound discovery collaborations in the pharmaceutical, biotechnology, agrochemical, and related industries, according to the company.

"We are extremely pleased to add Receptor Research to our operations," commented John McAlister, Tripos's president and CEO. "Their sterling reputation for creativity and high-quality, novel chemical synthesis complements that of Tripos for informatics and service among our customers. Working with Receptor and investing to significantly expand its laboratory operations, we will bring unprecedented capability to lead discovery and optimization partnerships." He concluded by saying the purchase will further the chemoinformatics company's goal of becoming a broad-based, international discovery partner to the pharmaceutical and related industries. The purchase is also a good fit with Tripos's recent investments in Arena Pharmaceuticals, a receptor identification, biology, and screening company, and Phase-1, a molecular toxicology screening company, McAlister stated.

As a result of the acquisition, Receptor will change its name to Tripos Receptor Research and hire additional staffers--including chemists and robotics experts--at its headquarters.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.